IRIS
PETRIOLI, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.106
EU - Europa 2.647
AS - Asia 501
SA - Sud America 17
AF - Africa 16
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.293
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.097
GB - Regno Unito 675
IE - Irlanda 552
CN - Cina 314
IT - Italia 291
SE - Svezia 249
RU - Federazione Russa 216
UA - Ucraina 213
DE - Germania 124
FR - Francia 115
SG - Singapore 100
FI - Finlandia 71
ES - Italia 40
BE - Belgio 35
VN - Vietnam 30
IN - India 25
LU - Lussemburgo 19
CI - Costa d'Avorio 12
CL - Cile 10
CA - Canada 9
IR - Iran 9
CZ - Repubblica Ceca 8
PL - Polonia 8
TR - Turchia 6
NL - Olanda 5
AU - Australia 4
BG - Bulgaria 4
BR - Brasile 4
RO - Romania 4
BD - Bangladesh 3
AL - Albania 2
CH - Svizzera 2
DK - Danimarca 2
GR - Grecia 2
HK - Hong Kong 2
HU - Ungheria 2
JP - Giappone 2
KZ - Kazakistan 2
LV - Lettonia 2
MW - Malawi 2
NO - Norvegia 2
PK - Pakistan 2
PT - Portogallo 2
AM - Armenia 1
AR - Argentina 1
EC - Ecuador 1
EG - Egitto 1
EU - Europa 1
IL - Israele 1
IQ - Iraq 1
MA - Marocco 1
MY - Malesia 1
NZ - Nuova Zelanda 1
RS - Serbia 1
SI - Slovenia 1
TH - Thailandia 1
TW - Taiwan 1
VE - Venezuela 1
Totale 6.293
Salva come PNG Salva come JPEG
Città #
Southend 629
Dublin 547
Fairfield 535
Ashburn 270
Woodbridge 250
Chandler 227
Ann Arbor 211
Wilmington 197
Cambridge 188
Seattle 183
Jacksonville 179
Houston 168
Princeton 89
Siena 86
Singapore 74
New York 64
Beijing 59
Nanjing 56
Shanghai 44
San Mateo 39
Helsinki 38
Málaga 36
Brussels 35
Boardman 30
Dong Ket 29
San Diego 26
Munich 25
Shenyang 22
Dallas 21
Los Angeles 19
Moscow 19
Nanchang 18
Jiaxing 15
Roodt-sur-Syre 14
Rome 13
Abidjan 12
Milan 12
Hebei 10
London 10
Venezia 10
Zhengzhou 9
Arezzo 8
Florence 8
Kunming 8
San Francisco 8
Santiago 8
Tianjin 7
Aosta 6
Dearborn 6
Fremont 6
Norwalk 6
Redwood City 6
Washington 6
Zanjan 6
Brno 5
Changsha 5
Düsseldorf 5
Lublin 5
Ningbo 5
Santa Clara 5
Taizhou 5
Tappahannock 5
Viareggio 5
Vijayawada 5
Guangzhou 4
Hangzhou 4
Leawood 4
Nuremberg 4
São José 4
Toronto 4
Bangalore 3
Jinan 3
Lastra a Signa 3
Livorno 3
Narni 3
New Bedfont 3
Santa Maria Capua Vetere 3
Winnipeg 3
Alessandria 2
Amsterdam 2
Andover 2
Bathinda 2
Bologna 2
Brentwood 2
Caorso 2
Columbus 2
Dresden 2
Espoo 2
Glasgow 2
Groningen 2
Gunzenhausen 2
Haikou 2
Hefei 2
Hong Kong 2
Hyderabad 2
Islington 2
Izmir 2
Kiskunfelegyhaza 2
Lanzhou 2
Lilongwe 2
Totale 4.749
Salva come PNG Salva come JPEG
Nome #
Efficacy and Safety of Regorafenib With 2/1 Schedule for Patients ≥ 75 Years With Metastatic Colorectal Cancer (mCRC) After Failure of 2 Lines of Chemotherapy 221
Pathological response and outcome after neoadjuvant chemotherapy with DOC (docetaxel, oxaliplatin, capecitabine) or EOF (epirubicin, oxaliplatin, 5-fluorouracil) for clinical T3-T4 non-metastatic gastric cancer 202
C-Met targeting in advanced gastric cancer: An open challenge 201
Monoclonal antibodies-based treatment in gastric cancer: current status and future perspectives 182
Strong Prognostic Value of Microsatellite Instability in Intestinal Type Non-cardia Gastric Cancer 180
Angiogenesis inhibitors in gastric and gastroesophageal junction cancer 173
Feasibility of modified docetaxel, oxaliplatin, capecitabine followed by capecitabine as maintenance chemotherapy as first-line therapy for patients with metastatic gastric or gastroesophageal cancer 172
Maintenance treatment with oral cyclophosphamide and bevacizumab in patients with recurrent epithelial ovarian cancer 155
Gemcitabine, oxaliplatin, and capecitabine (GEMOXEL) compared with gemcitabine alone in metastatic pancreatic cancer: a randomized phase II study 154
Sequential treatment with epirubicin, oxaliplatin and 5FU (EOF) followed by docetaxel, oxaliplatin and 5FU (DOF) in patients with advanced gastric or gastroesophageal cancer: a single-institution experience 150
CEA and CA19.9 as early predictors of progression in advanced/metastatic colorectal cancer patients receiving oxaliplatin-based chemotherapy and bevacizumab 149
Hyperthermic intraperitoneal chemotherapy for the treatment of ovarian cancer: A brief overview of recent results 147
28. Role of neoadjuvant chemotherapy with cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy for treatment of primary ovarian cancer with peritoneal carcinomatosis 146
Apatinib: A novel receptor tyrosine kinase inhibitor for the treatment of gastric cancer 143
Two-point-NGS analysis of cancer genes in cell-free DNA of metastatic cancer patients 139
Treatment of advanced oesophagogastric cancer with FOLFOX-4 regimen followed by leucovorin/bolus and continuous infusion 5-FU as maintenance chemotherapy in patients aged ≥ 75 years with impaired performance status 137
Gastric cancer: Current status of lymph node dissection 137
Analysis of biochemical bone markers as prognostic factors for survival in patients with hormone-resistant prostate cancer and bone metastases 133
Maximum androgen blockade in advanced prostate cancer: an overview of the randomised trials 124
Short-term and long-term risk factors in gastric cancer 121
Efficacy of Adjuvant Fluorouracil and Folinic Acid in B2 Colon Cancer 118
A novel treatment protocol with 6 cycles of neoadjuvant chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in stage III primary ovarian cancer 115
null 112
null 112
null 110
GEMCITABINE (dFdC), 5-FLUROURACIL (5FU), AND FOLINIC ACID (FA) IN THE TREATMENT OF PATIENTS WITH GASTRO-ENTERIC CARCINOMAS: A CLINICAL AND PHARMACOLOGICAL STUDY. 109
null 109
Hyperprogressive disease in advanced cancer patients treated with nivolumab: a case series study 109
null 103
Treatment of bone metastases with dichloromethylene bisphosphonate 100
Signet ring cell percentage in poorly cohesive gastric cancer patients: a potential novel predictor of survival 99
null 98
null 98
null 96
null 96
Capecitabine Plus Oxaliplatin and Bevacizumab, Followed by Maintenance Treatment With Capecitabine and Bevacizumab for Patients Aged > 75 Years With Metastatic Colorectal Cancer 96
A case of eribulin-induced regression of liposarcoma of the left funiculus in a heavily pretreated patient 93
The prognostic value of CD3+ tumor-infiltrating lymphocytes for stage II colon cancer according to use of adjuvant chemotherapy: A large single-institution cohort study: TILs for ADJ-untreated stage II colon cancer 90
null 89
null 88
null 87
Gemcitabine plus nab-paclitaxel followed by maintenance treatment with gemcitabine alone as first-line treatment for older adults with locally advanced or metastatic pancreatic cancer 85
Combined tamoxifen and luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist alone in premenopausal advanced breast cancer: A meta-analysis of four randomized trials 82
Preoperative or perioperative docetaxel, oxaliplatin, and capecitabine (GASTRODOC regimen) in patients with locally-advanced resectable gastric cancer: a randomized phase-II trial 70
A husband and a wife with simultaneous presentation of glioblastoma multiforme: a case report 63
Squamous cell carcinoma of the maxillary sinus: A retrospective analysis of 36 cases 63
An exceptional overall survival using bevacizumab beyond progression in a patient with Non-small cell lung cancer 60
Association of Concomitant Bone Resorption Inhibitors with Overall Survival among Patients with Metastatic Castration-Resistant Prostate Cancer and Bone Metastases Receiving Abiraterone Acetate with Prednisone as First-Line Therapy 56
Clinical value and impact on prognosis of peri-operative CA 19-9 serum levels in stage I and II adenocarcinoma of the pancreas 54
Epirubicin-based compared with docetaxel-based chemotherapy for advanced gastric carcinoma: A systematic review and meta-analysis 52
The percentage of signet ring cells is inversely related to aggressive behavior and poor prognosis in mixed-type gastric cancer 50
Structured and shared CT radiological report of gastric cancer: a consensus proposal by the Italian Research Group for Gastric Cancer (GIRCG) and the Italian Society of Medical and Interventional Radiology (SIRM) 49
Evolution and emerging future of cytoreducxtive surgery and hyperthermic intraperitoneal chemoperfusion in gastric cancer: From treating the incurable to preventing recurrence 49
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for treatment of ovarian cancer 49
Role of chemotherapy in the treatment of metastatic castration-resistant prostate cancer patients who have progressed after abiraterone acetate 47
Thymostimulin in Association with Chemotherapy in Breast Cancer Patients with Bone Metastases 46
Five years of stable disease with maintenance therapy using bevacizumab and tamoxifen in a patient with metastatic breast cancer 45
Tolerability of cabazitaxel in patients with metastatic castration-resistant prostate cancer progressing after docetaxel and abiraterone acetate: a single-institution experience. 41
Specific clonal expansion at disease progression (PD) in solid cancers pinpointed by cell free DNA analysis 40
null 39
Low-Dose Estramustine Phosphate and Concomitant Low-Dose Acetylsalicylic Acid in Heavily Pretreated Patients With Advanced Castration-Resistant Prostate Cancer. 34
Surgical management of advanced gastric cancer: An evolving issue 30
Cytoreduction surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) as treatment choice of metastatic Urachal carcinoma 29
Posterior and Para-Aortic (D2plus) Lymphadenectomy after Neoadjuvant/Conversion Therapy for Locally Advanced/Oligometastatic Gastric Cancer 22
Neuroendocrine tumors' patients treated with somatostatin analogue could complicate with emergency cholecystectomy 7
Totale 6.455
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.675
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.675
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020938 0 0 0 0 65 83 113 205 199 121 51 101
2020/20211.137 48 114 48 108 69 114 69 178 87 134 85 83
2021/2022717 57 63 50 45 30 38 32 32 34 72 97 167
2022/2023958 56 69 138 107 85 203 31 78 96 46 26 23
2023/2024908 33 16 87 45 27 234 306 9 0 45 48 58
2024/2025479 63 95 163 116 42 0 0 0 0 0 0 0
Totale 6.455